Inventor

Gary P. Kirschenheuter

Inventor
Arvada, CO, US

Overview

19→
Patents
1993–2007
Patent span
Chemistry
Primary field (CPC C)

Patents· 19 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Hprimary
C07HSugars15%
A61KPreparations for medical, dental or toiletry purposes14%
C12NMicroorganisms or enzymes12%
B82YSpecific uses or applications of nanostructures10%
C07DHeterocyclic compounds8%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms8%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations7%
C40BCombinatorial chemistry7%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
C07CAcyclic or carbocyclic compounds5%
PatentTitleYear
7,176,295'Systematic evolution of ligands by exponential enrichment: blended SELEX'20076,914,138'Urea nucleosides as therapeutic and diagnostic agents'20056,465,189'Systematic evolution of ligands by exponential enrichment: blended selex'20026,441,161'Urea nucleosides as therapeutic and diagnostic agents'20026,375,951'Therapeutic suppression of specific immune response by administration of oligomeric forms of antigen of controlled chemistry'20026,184,364'High affinity nucleic acid ligands containing modified nucleotides'20016,143,882'Urea nucleosides as therapeutic and diagnostic agents'20006,083,696'Systematic evolution of ligands exponential enrichment: blended selex'20006,022,544'Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry'20005,958,691'High affinity nucleic acid ligands containing modified nucleotides'19995,959,100'Pyrimidine nucleosides as therapeutic and diagnostic agents'19995,683,867'Systematic evolution of ligands by exponential enrichment: blended SELEX'19975,663,416'Oxidant sensitive and insensitive aromatic esters as inhibitors of human neutrophil elastase'19975,660,985'High affinity nucleic acid ligands containing modified nucleotides'19975,314,910'Ester inhibitors'19945,281,617'N-succinimidyl and N-phthalimidyl esters of 2-phenylalkanoic acid derivatives as inhibitors of human leukocyte elastase'19945,240,956'Ester inhibitors'19935,216,022'Aromatic esters of phenylenedialkanoates as inhibitors of human neutrophil elastase'19935,214,191'Oxidant sensitive and insensitive aromatic esters as inhibitors of human neutrophil elastase'1993

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1993–1997Patents assigned to CORTECH INC (6)· patent assignee history
1993–2007Based in Arvada, CO, US· patent location history
1997–2001Patents assigned to NEXSTAR PHARMACEUTICALS INC (7)· patent assignee history
2000–2002Patents assigned to UNIV JOHNS HOPKINS (2)· patent assignee history
2002–2007Patents assigned to GILEAD SCIENCES INC (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
NEXSTAR PHARMACEUTICALS INC71997–2001
CORTECH INC61993–1997
GILEAD SCIENCES INC42002–2007
UNIV JOHNS HOPKINS22000–2002
Locations
LocationPatentsSpan
Arvada, CO, US191993–2007